As shown by Jacob and colleagues [111], in a study of EAAT1, EAAT2 and glutamate receptors in AD brains, EAAT1 and EAAT2 gene and protein expression were already reduced in the early stages of AD progression, in hippocampus in gyrus frontalis medialis. Here, SLC1A2 is linked to Alzheimer disease.